Ignite Creation Date:
2024-05-05 @ 6:47 PM
Last Modification Date:
2024-10-26 @ 9:36 AM
Study NCT ID:
NCT00540072
Status:
COMPLETED
Last Update Posted:
2019-11-14
First Post:
2007-10-04
Brief Title:
Study of Cidecin Daptomycin to Rocephin Ceftriaxone in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S Pneumoniae
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-07-30
Start Date Type:
ACTUAL
Primary Completion Date:
2002-02-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-02-27
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-04
First Submit QC Date:
October 4 2007
Study First Post Date:
2007-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-13
Last Update Post Date:
2019-11-14
Last Update Post Date Type:
ACTUAL